(Q35672479)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14977385%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

review article

1 reference

title

Treatment of HIV infection in pregnant women: antiretroviral management options (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14977385%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14977385%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1

Mona R Loutfy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14977385%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14977385%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14977385%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14977385%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14977385%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

page(s)

471-488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14977385%20AND%20SRC:MED&resulttype=core&format=json

Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants

24 November 2019

cites work

1 reference

12 December 2020

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group

1 reference

12 December 2020

A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators

1 reference

12 December 2020

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

12 December 2020

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

1 reference

12 December 2020

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

1 reference

12 December 2020

Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades

1 reference

12 December 2020

Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women

1 reference

12 December 2020

Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines).

1 reference

12 December 2020

Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. The European Collaborative Study

1 reference

12 December 2020

HIV-infected pregnant women and vertical transmission in Europe since 1986. European collaborative study

1 reference

12 December 2020

Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)

1 reference

12 December 2020

Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant.

1 reference

12 December 2020

Maternal cell-free viremia in the natural history of perinatal HIV-1 transmission: a meta-analysis

1 reference

12 December 2020

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission

1 reference

12 December 2020

Quantitation of human immunodeficiency virus type 1 in breast milk

1 reference

12 December 2020

Antiretroviral therapy during pregnancy and the risk of an adverse outcome

1 reference

12 December 2020

Combination antiretroviral therapy and duration of pregnancy

1 reference

12 December 2020

HIV-1/AIDS and maternal and child health in Africa

1 reference

12 December 2020

Vaginal disinfection during labour for reducing the risk of mother-to-child transmission of HIV infection

1 reference

12 December 2020

Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial

1 reference

12 December 2020

Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study

1 reference

12 December 2020

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial

1 reference

12 December 2020

HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.

1 reference

12 December 2020

Codon 215 mutations in human immunodeficiency virus-infected pregnant women. Swiss Collaborative 'HIV and Pregnancy' Study

1 reference

12 December 2020

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues

1 reference

12 December 2020

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

1 reference

12 December 2020

The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy.

1 reference

12 December 2020

Myelomeningocele in a child with intrauterine exposure to efavirenz.

1 reference

12 December 2020

Maternal-fetal feline immunodeficiency virus transmission: timing and tissue tropisms

1 reference

12 December 2020

Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.

1 reference

12 December 2020

Determinants of HIV-1 shedding in the genital tract of women.

1 reference

12 December 2020

Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team

1 reference

12 December 2020

Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group

1 reference

12 December 2020

U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States

1 reference

12 December 2020

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

1 reference

12 December 2020

Nonlinear pharmacokinetics of efavirenz (DMP-266), a potent HIV-1 reverse transcriptase inhibitor, in rats and monkeys

1 reference

12 December 2020

Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study

1 reference

12 December 2020

Pregnancy and HIV infection: A european consensus on management

1 reference

12 December 2020

Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century

1 reference

12 December 2020

Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina

1 reference

12 December 2020

Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076.

1 reference

12 December 2020

Interaction between timing of perinatal human immunodeficiency virus infection and the design of preventive and therapeutic interventions

1 reference

12 December 2020

Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women

1 reference

12 December 2020

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

1 reference

12 December 2020

Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa

1 reference

12 December 2020

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

12 December 2020

Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group

1 reference

12 December 2020

Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial

1 reference

12 December 2020

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

1 reference

12 December 2020

Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.

1 reference

12 December 2020

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial

1 reference

12 December 2020

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

1 reference

12 December 2020

Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

12 December 2020

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

1 reference

12 December 2020

Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies

1 reference

12 December 2020

Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection.

1 reference

12 December 2020

Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts

1 reference

12 December 2020